110 related articles for article (PubMed ID: 27457413)
1. A patient with Parkinson's disease and dermatomyositis with serum anti-transcriptional intermediary factor 1-γ antibody.
Murase C; Muro Y; Nakanishi H; Katsuno M; Akiyama M
Eur J Dermatol; 2016 Dec; 26(6):617-618. PubMed ID: 27457413
[No Abstract] [Full Text] [Related]
2. Anti-MDA5 antibody-positive dermatomyositis with lethal progressive interstitial lung disease and advanced gastric cancer.
Yamaoka T; Doi C; Yokomi A; Tanemura A; Murota H; Tani M; Saruban H; Hamaguchi Y; Fujimoto M; Katayama I
Eur J Dermatol; 2014; 24(4):490-1. PubMed ID: 25075604
[No Abstract] [Full Text] [Related]
3. Presence of anti-transcriptional intermediary factor-1 gamma antibodies in a dermatomyositis patient with retroperitoneal cancer of unknown primary site.
Hori H; Ozeki Y; Kobashigawa T; Futsuhara K; Tanaka A; Watanabe E; Yabe H; Yago T; Fukuchi T; Sugawara H; Kotake S
Mod Rheumatol Case Rep; 2021 Jan; 5(1):62-68. PubMed ID: 33269651
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of serum levels of anti-transcriptional intermediary factor 1-γ antibody in patients with dermatomyositis.
Ikeda N; Yamaguchi Y; Kanaoka M; Ototake Y; Akita A; Watanabe T; Aihara M
J Dermatol; 2020 May; 47(5):490-496. PubMed ID: 32103537
[TBL] [Abstract][Full Text] [Related]
5. Triple cancers concurrently detected in a case of antitranscriptional intermediary factor-1γ antibody-positive dermatomyositis.
Kikuchi N; Ohashi T; Miura T; Nishibu A; Yamamoto T
Int J Dermatol; 2017 Dec; 56(12):1516-1517. PubMed ID: 28884788
[No Abstract] [Full Text] [Related]
6. Anti-transcriptional intermediary factor 1-γ antibody as a biomarker in patients with dermatomyositis.
Shimizu K; Kobayashi T; Kano M; Hamaguchi Y; Takehara K; Matsushita T
J Dermatol; 2020 Jan; 47(1):64-68. PubMed ID: 31638280
[TBL] [Abstract][Full Text] [Related]
7. Anti-TIF1-γ-positive young adult dermatomyositis with germ cell tumour.
Taki E; Shimizu M; Soeda Y; Shirai M; Muro Y
Eur J Dermatol; 2016 Dec; 26(6):623-624. PubMed ID: 27457276
[No Abstract] [Full Text] [Related]
8. A single-center, retrospective record review of malignancy prevalence in patients with dermatomyositis with anti-transcription intermediary factor 1γ antibodies via line immunoassay versus immunoprecipitation.
Westerdahl S; Hull CM; Clarke JT; Hansen CB; Rhoads JLW
J Am Acad Dermatol; 2021 Feb; 84(2):559-561. PubMed ID: 32619611
[No Abstract] [Full Text] [Related]
9. Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis.
Fujimoto M; Murakami A; Kurei S; Okiyama N; Kawakami A; Mishima M; Sato S; Seishima M; Suda T; Mimori T; Takehara K; Kuwana M
J Dermatol Sci; 2016 Dec; 84(3):272-281. PubMed ID: 27693019
[TBL] [Abstract][Full Text] [Related]
10. Use of Anti-transcriptional Intermediary Factor-1 Gamma Autoantibody in Identifying Adult Dermatomyositis Patients with Cancer: A Systematic Review and Meta-analysis.
Best M; Molinari N; Chasset F; Vincent T; Cordel N; Bessis D
Acta Derm Venereol; 2019 Mar; 99(3):256-262. PubMed ID: 30460368
[TBL] [Abstract][Full Text] [Related]
11. Case of anti-transcriptional intermediary factor-1-positive dermatomyositis associated with breast cancer developing over 10 years.
Matsushita T; Takehara K; Oishi K; Maeda S; Hamaguchi Y; Ishikawa S; Inokuchi M; Michiwa Y; Takehara K
J Dermatol; 2017 Aug; 44(8):972-973. PubMed ID: 27607893
[No Abstract] [Full Text] [Related]
12. Anti-transcription intermediary factor 1-γ antibody-positive clinically amyopathic dermatomyositis complicated by interstitial lung disease and breast cancer.
Ogawa M; Sugiura K; Yokota K; Muro Y; Akiyama M
J Eur Acad Dermatol Venereol; 2016 Feb; 30(2):373-5. PubMed ID: 25346167
[No Abstract] [Full Text] [Related]
13. Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies.
Muro Y; Ishikawa A; Sugiura K; Akiyama M
Rheumatology (Oxford); 2012 Aug; 51(8):1508-13. PubMed ID: 22539482
[TBL] [Abstract][Full Text] [Related]
14. Anti-TIF1γ antibody predicted malignancy of thymic tumor with dermatomyositis as an "autoimmune tumor marker": A case report.
Karino K; Fujieda Y; Kawamura T; Abe N; Shimoyama S; Kono M; Kato M; Yasuda S; Atsumi T
Medicine (Baltimore); 2018 Dec; 97(49):e13563. PubMed ID: 30544475
[TBL] [Abstract][Full Text] [Related]
15. A Case of Dermatomyositis Along with Esophageal Cancer and Screening of Serum Transcriptional Intermediary Factor 1 Gamma Antibodies in Various Cancer Patients.
Sumazaki M; Kaneko K; Ito M; Oshima Y; Saito F; Ogata H; Shibuya K; Shimada H
Am J Case Rep; 2020 Apr; 21():e922004. PubMed ID: 32312948
[TBL] [Abstract][Full Text] [Related]
16. Clinically amyopathic dermatomyositis with anti-transcriptional intermediary factor 1-γ autoantibody positivity.
Kanaoka M; Yamaguchi Y; Watanabe T; Akita A; Ototake Y; Ikeda N; Aihara M
Rheumatology (Oxford); 2020 Oct; 59(10):e68-e69. PubMed ID: 32259242
[No Abstract] [Full Text] [Related]
17. Pregnancy triggers the onset of anti-transcriptional intermediary factor 1γ antibody-positive dermatomyositis: a case series.
Oya K; Inoue S; Saito A; Nakamura Y; Ishitsuka Y; Fujisawa Y; Watanabe R; Taguchi S; Fujimoto M; Okiyama N
Rheumatology (Oxford); 2020 Jun; 59(6):1450-1451. PubMed ID: 31665457
[No Abstract] [Full Text] [Related]
18. Small Cell Lung Cancer Patient with Anti-transcriptional Intermediary Factor 1γ Antibody Who Developed Dermatomyositis after Successful Chemoradiotherapy.
Aritomi T; Kido T; Nakano K; Satoh Y; Noguchi S; Jotatsu T; Hanaka T; Satoh M; Tanaka Y; Yatera K
Intern Med; 2019 Feb; 58(3):427-431. PubMed ID: 30210109
[TBL] [Abstract][Full Text] [Related]
19. Amyopathic dermatomyositis with anti-TIF1 gamma antibodies.
Schiffmann ML; Warneke VS; Ehrchen J
J Dtsch Dermatol Ges; 2018 Jan; 16(1):76-78. PubMed ID: 29232033
[No Abstract] [Full Text] [Related]
20. Intramuscular haemorrhage in a patient with dermatomyositis and anti-TIF1γ antibodies.
Adachi R; Muro Y; Kono M; Akiyama M
Eur J Dermatol; 2018 Feb; 28(1):116-118. PubMed ID: 29521630
[No Abstract] [Full Text] [Related]
[Next] [New Search]
